Abstract
Background: A relationship between constitutional signs in patients with cardiac myxoma and interleukin‐6 has been Noted. However, there is little information about characteristics of cardiac myxomas associated with constitutional signs.
Hypothesis: The objective of this study was to clarify the characteristics of myxoma patients who had constitutional signs.
Methods: Questionnaires were sent to cardiology or cardiovascular surgery divisions at university hospitals throughout Japan. Constitutional signs were considered present when a patient had fever, weight loss, or elevations of C‐reactive protein or gammaglobulin. In addition, interleukin‐6 concentrations were evaluated in some patients.
Results: Data were obtained in 249 patients with primary cardiac tumors (204 myxomas, 15 other primary benign tumors, and 30 primary malignant tumors), confirmed histologically between 1993 and 1996. Fever and weight loss were observed in 15 and 6% of patients with myxoma, respectively, while C‐reactive protein and gammaglobulin were increased in 39 and 21%, respectively. This amounted to a prevalence of constitutional signs in 49%. All constitutional signs disappeared after tumor resection. Age, gender, tumor site, and frequency of thrombosis did Not differ between patients with and without constitutional signs. Tumors associated with constitutional signs were significantly more likely to be large, multiple, or recurrent than those unassociated with constitutional signs.
Conclusions: Constitutional signs are present in about half of patients with myxoma. Large or multicentric tumors are likely to induce constitutional signs, which are reversible upon resection. These might suggest that constitutional signs result when interleukin‐6 concentrations exceed a certain threshold.
Keywords: cardiac myxoma, constitutional signs, autoimmune disease
Full Text
The Full Text of this article is available as a PDF (24.0 KB).
References
- 1. Endo A, Ohtahara A, Kinugawa T, Mori M, Fujimoto Y, Yoshida A, Kuroda H, Mori T, Mashiba H, Shigemasa C: Characteristics of 161 patients with cardiac tumors diagnosed during 1993 and 1994 in Japan. Am J Cardiol 1997; 79:1708–1711 [DOI] [PubMed] [Google Scholar]
- 2. Fyke FE, Seqard JB, Edwards WD, Miller FA Jr, Reeder GS, Schattenberg TT, Schub C, Callahan JA, Tajik AJ: Primary cardiac tumors: Experience with 30 consecutive patients since the introduction of two‐dimensional echocardiography. J Am Coll Cardiol 1985; 5:1465–1473 [DOI] [PubMed] [Google Scholar]
- 3. St. John Sutton MG, Mercier LA, Giuliani ER, Lie JT: A review of clinical experience in 40 patients. Mayo Clin Proc 1980; 55:371–376 [PubMed] [Google Scholar]
- 4. Chen HZ, Jiang L, Rong WH, Wang JS, Shen C, Shi YF, Pu SY: Tumors of the heart. An analysis of 79 cases. Chin Med J 1992; 105:153–158 [PubMed] [Google Scholar]
- 5. Blondeau P: Primary cardiac tumors. French studies of 533 cases. Thorac Cardiovasc Surg 1990; 38:192–195 [DOI] [PubMed] [Google Scholar]
- 6. Parissis JT, Mentzikof D, Georgopoulou M, Gikopoulos M, Kanapitsas A, Merkouris K, Kefalas C: Correlation of interleukin‐6 gene expression to immunologic features in patients with cardiac myxomas. J Interferon Cytokine Res 1996; 16:589–593 [DOI] [PubMed] [Google Scholar]
- 7. Saji T, Yanagawa E, Matsuura H, Yamamoto S, Ishikita T, Matsuo N, Yoshirwara K, Takanashi Y: Increased serum interleukin‐6 in cardiac myxoma. Am Heart J 1991; 122:579–580 [DOI] [PubMed] [Google Scholar]
- 8. Seino Y, Ikeda U, Shimada K: Increased expression of interleukin 6 mRNA in cardiac myxomas. Br Heart J 1993; 69:565–567 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 9. Hirano T, Taga T, Yasukawa K, Nakajima K, Nakano N, Takatsuki F, Shimizu M, Murashima A, Tsunasawa S, Sakiyama F, Kishimoto T: Human B‐cell differentiation factor defined by an anti‐peptide antibody and its possible role in autoantibody production. Proc Natl Acad Sci 1987; 84:228–231 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 10. Wong GG, Clark SC: Multiple actions of interleukin 6 within a cytokine Network. Immunol Today 1988; 9:137–139 [DOI] [PubMed] [Google Scholar]
- 11. Seguin JR, Beigbeder JY, Hvass U, Langlois J, Grolleau R, Jourdan M, Klein B, Bataille R, Chaptal PA: Interleukin 6 production by cardiac myxomas may explain constitutional symptoms. J Thorac Cardiovasc Surg 1992; 103:599–600 [PubMed] [Google Scholar]
- 12. Fang BR, Chiang CW, Hung JS, Lee YS, Chang CS: Cardiac myxoma—clinical experience in 24 patients. Int J Cardiol 1990; 29:335–341 [DOI] [PubMed] [Google Scholar]
- 13. Currey HL, Mathews JA, Robinson J: Right atrial myxoma mimicking a rheumatic disorder. Br Med J 1967; 1:547–548 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 14. Kaminsky P, Klein M, Pinelli G, Grasser B, Duc M, Villemot JP: Positive lupus band test in cardiac myxoma (letter). Lancet 1992; 340:1100 [DOI] [PubMed] [Google Scholar]
- 15. Wiedermann CJ, Reinisch N, Fischer Colbrie R, Vollmar AM, Herold M, Knapp E: Proinflammatory cytokines in cardiac myxomas. J Intern Med 1992; 232:263–265 [DOI] [PubMed] [Google Scholar]
- 16. Soeparwata R, Poeml P, Schmid C, Neuhof H, Scheld HH: Interleukin‐6 plasma levels and tumor size in cardiac myxoma. J Thorac Cardiovasc Surg 1996; 112:1675–1677 [DOI] [PubMed] [Google Scholar]
- 17. McCarthy PM, Piehler JM, Schaff HV, Pluth JR, Orszulak TA, Vidaillet HJ Jr, Carney JA: The significance of multiple, recurrent, and “complex” cardiac myxomas. J Thorac Cardiovasc Surg 1986; 91:389–396 [PubMed] [Google Scholar]
- 18. Mochizuki Y, Okamura Y, Iida H, Mori H, Shimada K: Interleukin‐6 and “complex” cardiac myxoma. Ann Thorac Surg 1998; 66:931–933 [DOI] [PubMed] [Google Scholar]